Inventor
SCHOENHAUT DAVID
US14 patents
⚠️ This page may combine multiple inventors who share the name “SCHOENHAUT DAVID”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BASF AG
5 patentsUS6509015B1Jan 21, 2003
Human antibodies that bind human TNFa
BASF AG407 citations99
US6258562B1Jul 10, 2001
Human antibodies that bind human TNFα
BASF AG650 citations99
US6090382AJul 18, 2000
Human antibodies that bind human TNFα
BASF AG894 citations99
US5510461AApr 23, 1996
pp: A newly identified CD45-associated protein
BASF AG2 citations57
US5846822ADec 8, 1998
Nucleic acid molecules encoding PP32: a newly identified CD45-associated protein
BASF AG1 citations47
ABBOTT BIOTECH LTD
5 patentsUS8372401B2Feb 12, 2013
Human antibodies that bind human TNFα
ABBOTT BIOTECH LTD83 citations98
US8372400B2Feb 12, 2013
Methods of treating disorders using human antibodies that bind human TNFα
ABBOTT BIOTECH LTD83 citations98
US7588761B2Sep 15, 2009
Human antibodies that bind human TNFα
ABBOTT BIOTECH LTD177 citations98
US7541031B2Jun 2, 2009
Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα
ABBOTT BIOTECH LTD186 citations98
US7223394B2May 29, 2007
Human antibodies that bind human TNFα
ABBOTT BIOTECH LTD223 citations98
SALFELD JOCHEN G
4 patentsUS8414894B2Apr 9, 2013
Human antibodies that bind human TNFα and methods of using same
SALFELD JOCHEN G85 citations98
US8206714B2Jun 26, 2012
Methods for treating rheumatoid arthritis using human antibodies that bind human TNFa
SALFELD JOCHEN G87 citations98
US8197813B2Jun 12, 2012
Human antibodies that bind human TNFα
SALFELD JOCHEN G86 citations98
US8753633B2Jun 17, 2014
Human antibodies that bind human TNFα
SALFELD JOCHEN G50 citations97